0001062993-15-006419.txt : 20151124 0001062993-15-006419.hdr.sgml : 20151124 20151124174804 ACCESSION NUMBER: 0001062993-15-006419 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151120 FILED AS OF DATE: 20151124 DATE AS OF CHANGE: 20151124 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wegman Thomas CENTRAL INDEX KEY: 0001355189 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 151253766 MAIL ADDRESS: STREET 1: 1764 BRIAR PLACE CITY: MERRICK STATE: NY ZIP: 11566 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2015-11-20 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001355189 Wegman Thomas C/O BIOSPECIFICS TECHNOLOGIES CORP., 35 WILBUR STREET LYNBROOK NY 11563 1 1 1 0 President & CEO Common Stock, $0.001 par value 2015-11-20 4 S 0 4077 50.048 D 132745 D Common Stock, $0.001 par value 2015-11-23 4 S 0 9923 50.1039 D 122822 D The selling price of $50.048 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $50.00 to $50.2401. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. The selling price of $50.1039 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $50.00 to $50.15. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Carl A. Valenstein, attorney-in-fact for Thomas Wegman 2015-11-24